Stimulants and cardiovascular events in youth with attention-deficit/ hyperactivity disorder

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 51, Issue 2, 2012, Pages 147-156

  Olfson, Mark ^a   Huang, Cecilia ^b   Gerhard, Tobias ^c   Winterstein, Almut G ^d   Crystal, Stephen ^b   Allison, Paul D ^e   Marcus, Steven C ^e  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

attention deficit hyperactivity disorder; cardiovascular events; drug safety; pharmacoepidemiology; stimulants

Indexed keywords

AMPHETAMINE DERIVATIVE; METHYLPHENIDATE;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ANGINA PECTORIS; ARTICLE; ATTENTION DEFICIT DISORDER; CARDIOVASCULAR RISK; CHILD; COHORT ANALYSIS; DISEASE SEVERITY; DRUG EXPOSURE; EMERGENCY WARD; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; JUVENILE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SYNCOPE; TACHYCARDIA; TRANSIENT ISCHEMIC ATTACK;

ADOLESCENT; AMPHETAMINES; ANGINA PECTORIS; ARRHYTHMIAS, CARDIAC; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COHORT STUDIES; DRUG TOXICITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; METHYLPHENIDATE; ODDS RATIO; PROPENSITY SCORE; SYNCOPE; TACHYCARDIA; YOUNG ADULT;

EID: 84855990120     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1016/j.jaac.2011.11.008     Document Type: Article

References (61)

1. M.L. Wolraich, J.N. Hannah, T.Y. Pinnock, A. Baumgaertel, J. Brown Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample J Am Acad Child Adolesc Psychiatry 35 1996 319 324 (Pubitemid 26072289)
2. D. Shaffer, P. Fisher, M.K. Dulcan The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study Methods for the Epidemiology of Child and Adolescent Mental Disorders Study J Am Acad Child Adoles Psychiatry 35 1996 865 877 (Pubitemid 26230920)
3. K.R. Merikangas, J.P. He, M. Burstein Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey ReplicationAdolescent Supplement (NCS-A) J Am Acad Child Adolesc Psychiatry 49 2010 980 989
4. American Academy of Child and Adolescent Psychiatry Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry. 46 2007 894 921
5. American Academy of Pediatrics Subcommittee on Attention-Deficit/ Hyperactivity Disorder and Committee on Quality Improvement Clinical practice guideline: treatment of the school-aged child with attention deficit/hyperactivity disorder Pediatrics 108 2001 1033 1044
6. S.H. Zuvekas, B. Vitiello, G.S. Norquist Recent trends in stimulant medication use among U.S. children Am J Psychiatry 163 2006 579 585 (Pubitemid 44464565)
7. MTA Cooperative Group A 14-month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder Arch Gen Psychiatry 56 1999 1073 1086
8. Physicians' Desk Reference 2010 61st ed 2011 Medical Economics Company Montvale, NJ
9. FDA Drug Safety Communication Safety review update of medications used to treat attention-deficit/hyperactivity disorder (ADHD) in children and young adults http://www.fda.gov/Drugs/DrugSafety/ucm277770.htm Accessed February 22, 2011
10. Office of Drug Safety Follow Up Review of AERS Search Identifying Cases of Sudden Death Occurring with Drugs Used for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) 2006 US Food and Drug Administration Rockville, MD www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4210b-07-01-safetyreview.pdf Accessed February 22, 2011
11. A.L. Cohen, M.A. Jhung, D.S. Budnitz Stimulant medications and attention deficit-hyperactivity disorder N Engl J Med 354 2006 2294 2295 (Pubitemid 43788161)
12. V.L. Vetter, J. Elia, C. Erickson Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing Circulation 117 2008 2407 2423 (Pubitemid 351653546)
13. J.A. Samuels, K. Franco, F. Wan, J.M. Sorof Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial Pediatr Nephrol 21 2006 92 95 (Pubitemid 43040200)
14. J. Graham, D. Coghill Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management CNS Drugs 22 2008 21 237
15. M. El Hajjar, J.S. Hermida, F.M. Caron, D. Nassif, E. Bourges-Petit, Y. Maingourd Tachycardia-induced cardiomyopathy in children: a difficult diagnosis but a reversible form of left ventricular dysfunction Arch Pediatr 11 2004 24 28 (Pubitemid 38049351)
16. E. Umana, C.A. Solares, M.A. Alpert Tachycardia-induced cardiomyopathy Am J Med 114 2003 51 55 (Pubitemid 36126516)
17. S.C. Grant, D.H. Bennett Cardiomyopathy secondary to sinus tachycardia Int J Cardiol 40 1993 173 175 (Pubitemid 23211243)
18. J.S. Shinbane, M.A. Wood, D.N. Jensen, K.A. Ellenbogen, A.P. Fitzpatrick, M.M. Scheinman Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies J Am Coll Cardiol 15 1997 709 715 (Pubitemid 27128241)
19. A.G. Winterstein, T. Gerhard, J. Shuster, M. Johnson, J.M. Zito, A. Saidi Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder Pediatrics 120 2007 e1494 e1501
20. A.G. Winterstein, T. Gerhard, J. Shuster, A. Saidi Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD Pediatrics 124 2009 e74 e80
21. S. McCarthy, N. Cranswick, L. Potts, E. Taylor, I.C.K. Wong Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the General Practice Research Database Drug Saf 32 2009 1089 1096
22. H. Schelleman, W.B. Bilker, B.L. Strom Cardiovascular events and death in children exposed and unexposed to ADHD agents Pediatrics 127 2011 1102 1110
23. W.O. Cooper, L.A. Habel, C.M. Sox ADHD drugs and serious cardiovascular events in children and young adults [published online ahead of print November 1, 2011] N Engl J Med 2011 10.1056/NEJMoa1110212
24. D.M. Adamson, S. Chang, L.G. Hansen White Paper: Health Research Data for the Real World: The MarketScan Databases 2006 Thomson Medstat Ann Arbor, MI
25. W.A. Ray Evaluating medication effects outside of clinical trials: new user designs Am J Epidemiol 158 2003 915 920 (Pubitemid 37323253)
26. L.C. Jordan Stroke in childhood Neurology 12 2006 94 102
27. W.T. Mahle, R.M. Campbell, J. Favalario-Sabatier Myocardial infarction in adolescents J Pediatr 151 2007 150 154 (Pubitemid 47069394)
28. W.D. Rosamond, L.E. Chambless, R.D. Sorlie Trends in the sensitivity, positive predictive value, false positive rate, and comparability ratio of hospital discharge diagnosis codes for acute myocardial infarction in four US communities, 1987-2000 Am J Epidemiol 12 2004 1137 1146 (Pubitemid 39628053)
29. Y. Kiyota, S. Schneeweiss, R.J. Glynn, C.C. Cannuscio, J. Avorn, D.H. Solomon Accuracy of Medicare claims based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records Am Heart J 148 2004 99 104 (Pubitemid 38900487)
30. D.L. Tirshwell, W.T. Longstreth Validating administrative data in stroke research Stroke 33 2002 2465 2470
31. L.B. Goldstein Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke effect of modifier codes Stroke 29 1998 1602 1604 (Pubitemid 28365581)
32. A.A. Chun, S.R. McGee Bedside diagnosis of coronary artery disease: a systematic review Am J Med 117 2004 334 343 (Pubitemid 39164566)
33. T.M. Kashner Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs Med Care 36 1998 1324 1336 (Pubitemid 128452863)
34. L.B. Goldstein, D.L. Simel Is this patient having a stroke? JAMA 293 2005 2391 2402 (Pubitemid 40684479)
35. P.G. Arbogast, W.A. Ray Use of disease risk scores in pharmacoepidemiologic studies Stat Med Med Res 18 2009 67 80
36. T. Gerhard, A.G. Winterstein, M. Olfson, C. Huang, A. Saidi, S. Crystal Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD Pharmacoepidemiol Drug Saf 19 2010 457 464
37. S. Hennessy, H. Schelleman, G.W. Daniel Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study Pharmacoepidemiol Drug Saf 19 2010 934 941
38. M.L. Wolraich, L.L. Greenhilll, W. Pelham Randomized, controlled, trial of OROS methylphenidate once a day in children with ADHD Pediatrics 108 2001 883 892 (Pubitemid 32947657)
39. R.B. D'Agostino Propensity scores in cardiovascular research Circulation 115 2007 2340 2343
40. R.B. D'Agostino, M.L. Lee, A.J. Belanger, L.A. Cupples, K. Anderson, W. Kannel Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study Stat Med 9 1990 1501 1515
41. J. Elia, V.L. Vetter Cardiovascular effects of medications for the treatment of attention-deficit hyperactivity disorder: what is known and how should it influence prescribing in children? Pediatr Drugs 12 2010 165 175
42. S.H. Kollins ADHD, substance use disorders, and psychostimulant treatment current literature and treatment guidelines J Atten Disord 12 2008 115 125
43. A.V. Chobanian, G.L. Bakris, H.R. Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572 (Pubitemid 37430158)
44. S. Port, L. Demer, R. Jennrich, D. Walter, A. Garfinkel Systolic blood pressure and mortality Lancet 355 2000 175 180 (Pubitemid 30068215)
45. P. Palatini, S. Julius Elevated heart rate: a major risk factor for cardiovascular disease Clin Exp Hyertens 26 2004 637 644 (Pubitemid 40129752)
46. S.C. Larsson, S. Mannisto, M.J. Virtanen Coffee and tea consumption and risk of stroke subtypes in male smokers Stroke 39 2008 1681 1687
47. L.F. Andersen, D.R. Jacobs Jr, M.H. Carlsen, R. Blomhoff Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study Am J Clin Nutr 83 2006 1039 1046 (Pubitemid 44713102)
48. J.S. Bonita, M. Mandarano, D. Shuta, J. Vinson Coffee and cardiovascular disease: In vitro, cellular, animal, and human studies Pharmacol Res 55 2007 187 198 (Pubitemid 46518151)
49. B.N. Frey, M.R. Martins, F.C. Petronilho Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania Bipolar Disord 8 2006 275 280
50. G.J. Klein How to manage and evaluate asymptomatic arrhythmias Can J Cardiol 10 1994 327 329 (Pubitemid 24135879)
51. K. Rajagopalan, J.E. Potts, S. Sanatani Minimally invasive approach to the child with palpitations Expert Rev Cardiovasc Ther 4 2006 681 693 (Pubitemid 44734239)
52. K.A. McLeod Syncope in childhood Arch Dis Child 88 2003 350 353 (Pubitemid 36398982)
53. R. Levy, B.J. O'Brien, C. Sellors, P. Grootendorst, D. Willison Coding accuracy of administrative drug claims in the Ontario Drug Benefit database Can J Clin Pharmacol 10 2003 67 71 (Pubitemid 37028596)
54. S. Macintyre, N. Mutrie Socioeconomic differences in cardiovascular disease and physical activity: stereotypes and reality J R Soc Health 124 2004 66 69 (Pubitemid 38444025)
55. J. Holohan, A. Cook The US economy and changes in health insurance coverage, 2000-2006 Health Aff 2 2008 w135 w144
56. M.D. Sztajnkrycer, S. Hariharan, R. Bond Cardiac irritability and myocardial infarction in a 13-year-old girl following recreational amphetamine overdose Pediatr Emerg Care 18 2002 E11 E15
57. G.E. Packe, M.J. Garton, K. Jennings Acute myocardial infarction caused by intravenous amphetamine abuse Br Heart J 64 1990 23 24 (Pubitemid 20222210)
58. M.S. Gould, B.T. Walsh, J.L. Munfakh Sudden death and use of stimulant medications in youths Am J Psychiatry 166 2009 992 1001
59. B. Morentin, B. Aguilera, P.M. Garamendi, M.P. Suarez-Mier Sudden unexpected non-violent death between 1 and 19 years in north Spain Arch Dis Child 82 2000 456 461 (Pubitemid 30367053)
60. N. Molander Sudden natural death in later childhood and adolescence Arch Dis Child 52 1982 572 576 (Pubitemid 12039937)
61. J.M. Perrin, R.A. Friedman, T.K. Knilans Black Box Working Group, Section on Cardiology and Cardiac Surgery Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder Pediatrics 122 2008 451 453